文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

治疗性血浆置换对高甘油三酯血症相关急性胰腺炎器官衰竭持续时间的影响

Impact of therapeutic plasmapheresis on the duration of organ failure in patients with hypertriglyceridemia-associated acute pancreatitis.
PubMed 文献 · Ann Intensive Care · 2024-04-15
一句话结论在高甘油三酯血症相关急性胰腺炎伴早期器官衰竭患者中,血浆置换未加速器官衰竭缓解,却与更多ICU入住相关。

本研究基于多中心、前瞻性、长期运行登记库(PERFORM)中2020年11月至2023年3月的数据,纳入122例入院72小时内且入组时存在器官衰竭的高甘油三酯血症相关急性胰腺炎(HTG-AP)患者(入组时SOFA评分中位数3.00[2.00-4.00])。46例接受血浆置换,76例仅药物治疗。调整基线甘油三酯、APACHE II评分、呼吸衰竭、心血管衰竭和肾衰竭等混杂因素后,血浆置换与器官衰竭缓解时间无显著差异(HR=1.07;95%CI 0.68-1.68;P=0.777)。血浆置换组ICU入住率更高(97.8%[45/46] vs. 65.8%[50/76];OR 19.33;95%CI 2.20-169.81;P=0.008)。作者认为,在HTG-AP伴早期器官衰竭患者中,血浆置换未加速器官衰竭缓解,但可能与更多ICU入住相关。

要点

  • 在HTG-AP伴早期器官衰竭患者中,调整混杂因素后血浆置换与器官衰竭缓解时间无显著差异(HR=1.07;95%CI 0.68-1.68;P=0.777)。
  • 血浆置换组ICU入住率97.8%(45/46),药物治疗组65.8%(50/76),OR 19.33(95%CI 2.20-169.81;P=0.008)。
  • 研究纳入122例入组时存在器官衰竭的HTG-AP患者,入组时SOFA评分中位数3.00(2.00-4.00)。
  • 混杂因素包括基线血清甘油三酯、APACHE II评分、呼吸衰竭、心血管衰竭和肾衰竭。
  • 作者认为,血浆置换未加速器官衰竭缓解,但可能与更多ICU入住相关。

适用人群与场景

  • 来自多中心、前瞻性、长期运行登记库(PERFORM)的HTG-AP患者,症状发作72小时内入院。
  • 纳入分析者为入组时存在器官衰竭的患者。
  • 数据收集时间为2020年11月至2023年3月。

研究设计与关键结果

  • 研究类型:基于多中心、前瞻性、长期运行登记库(PERFORM)的队列分析;纳入122例HTG-AP伴器官衰竭患者,入组时SOFA评分中位数3.00(2.00-4.00)。
  • 干预与对照:46例接受血浆置换,76例仅接受药物治疗。
  • 主要终点:14天内器官衰竭缓解时间;调整基线血清甘油三酯、APACHE II评分、呼吸衰竭、心血管衰竭和肾衰竭后,血浆置换组与药物治疗组无显著差异(HR=1.07;95%CI 0.68-1.68;P=0.777)。
  • 次要终点:血浆置换组ICU入住率97.8%(45/46),药物治疗组65.8%(50/76),OR 19.33(95%CI 2.20-169.81;P=0.008)。

证据类型、等级与局限

  • 证据类型:基于多中心、前瞻性、长期运行登记库(PERFORM)的队列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在HTG-AP伴早期器官衰竭患者中,血浆置换未加速器官衰竭缓解,但可能与更多ICU入住相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Plasmapheresis is widely used for severe hypertriglyceridemia-associated acute pancreatitis (HTG-AP) to remove excessive triglycerides from plasma. This study aimed to evaluate whether plasmapheresis could improve the duration of organ failure in HTG-AP patients.

METHODS: We analyzed a cohort of patients from a multicenter, prospective, long-running registry (the PERFORM) collecting HTG-AP patients admitted to the study sites within 72 h from the onset of symptoms. This study was based on data collected from November 2020 to March 2023. Patients who had organ failure at enrollment were involved in the analyses. The primary outcome was time to organ failure resolution within 14 days. Multivariable Cox regression model was used to evaluate the association between plasmapheresis and time to organ failure resolution. Directed acyclic graph (DAG) was used to identify potential confounders.

RESULTS: A total of 122 HTG-AP patients were included (median [IQR] sequential organ failure assessment (SOFA) score at enrollment, 3.00 [2.00-4.00]). Among the study patients, 46 underwent plasmapheresis, and 76 received medical treatment. The DAG revealed that baseline serum triglyceride, APACHE II score, respiratory failure, cardiovascular failure, and renal failure were potential confounders. After adjusting for the selected confounders, there was no significant difference in time to organ failure resolution between patients undergoing plasmapheresis and those receiving exclusive medical treatment (HR = 1.07; 95%CI 0.68-1.68; P = 0.777). Moreover, the use of plasmapheresis was associated with higher ICU requirements (97.8% [45/46] vs. 65.8% [50/76]; OR, 19.33; 95%CI 2.20 to 169.81; P = 0.008).

CONCLUSIONS: In HTG-AP patients with early organ failure, plasmapheresis was not associated with accelerated organ failure resolution compared to medical treatment but may be associated with more ICU admissions.

TRIAL REGISTRATION: The PERFORM study was registered in the Chinese Clinical Trial Registry (ChiCTR2000039541). Registered 30 October 2020.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Wang L, Zhou J, Lv C, et al. Impact of therapeutic plasmapheresis on the duration of organ failure in patients with hypertriglyceridemia-associated acute pancreatitis. Ann Intensive Care. 2024. PMID: 38619686. doi:10.1186/s13613-024-01285-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。